That is why «early
diagnosis is the best tool we have to date for saving patients.In fact, patients with early -
stage melanoma have a survival rate of 95 %, while5 - year survival
falls to 50 % in patients with metastasis,» explained Yoana Arroyo, researcher in the UPV / EHU's department of Cell Biology and Histology, where this research was carried out.